Skip to main content
. 2019 Apr 5;12:210. doi: 10.1186/s13104-019-4244-x

Table 1.

Association between selected factors with erectile dysfunction

Characteristics (variables) Status of erectile dysfunction Level of significance and odds ratio with 95% CI
Presence Absence Total
Age above 40** 187 (57.4%) 87 (26.7%) 274 (84.0%) P < 0.0001, OR: 3.73 (CI 2.01–6.93)
Type of diabetes** P-0.014, OR: 3.66 (CI 1.22–10.96)
 Type 1 5 (1.5%) 10 (3.1%) 15 (4.6%)
 Type 2 201 (61.6%) 110 (33.7%) 311 (95.4%)
Duration of diabetes** > 5 years 111 (34.0%) 31 (9.5%) 142 (43.6%) P < 0.0001, OR: 3.35 (CI 2.05–5.49)
Poor diabetic control (HbA1C ≥ 7) 135 (41.4%) 67 (20.6%) 202 (62.0%) P-0.082, OR: 1.50 (CI 0.95–2.38)
Unsafe level of alcohol consumption** 82 (25.2%) 26 (8.0%) 108 (33.1%) P-0.001, OR: 1.34 (CI 1.14–1.56)
Smoker 50 (15.3%) 21 (6.4%) 71 (21.8%) P-0.153, OR: 0.66 (CI 0.38–1.17)
With micro-vascular complications** 105 (32.2%) 44 (13.5%) 149 (45.7%) P-0.012, OR: 1.80 (CI 1.11–2.85)
With diabetic neuropathy** 40 (12.3%) 10 (3.1%) 50 (15.3%) P-0.007, OR: 1.33 (CI 1.12–1.57)
With diabetic nephropathy** 64 (19.6%) 19 (5.8%) 83 (25.5%) P-0.002, OR: 1.32 (CI 1.13–1.54)
With retinopathy 49 (15.0%) 23 (7.1%) 72 (22.1%) P-0.332, OR: 0.76 (CI 0.44–1.33)
With macro vascular complications 23 (7.1%) 7 (2.2%) 30 (9.2%) P-0.108, OR: 2.03 (CI 0.843–4.88)
Co-existing hypertension** 113 (34.7%) 39 (12.0%) 152 (46.6%) P < 0.0001, OR: 1.39 (CI 1.18–1.64)
Hyperlipidaemia 95 (29.1%) 50 (15.3%) 145 (44.5%) P < 0.436, OR: 1.07 (CI 0.91–1.26)
Taking beta-blockers** 13 (4.0%) 1 (0.3%) 14 (4.3%) P = 0.019, OR: 1.50 (CI 1.27–1.78)
BMI ≥ 25** 94 (28.8%) 39 (12.0%) 133 (40.8%) P = 0.035, OR: 1.74 (CI 1.09–2.79)

**Significant factors